Xeltis

Xeltis Overview

Founded 2006
Founded
Status Private
Employees 30
Employees
Latest Deal Type Series D
Latest Deal Amount $11.7M
Latest Deal Amount
Investors 6

Xeltis General Information

Description

Operator of a clinical-stage medical device company pioneering a restorative approach in cardiovascular therapy. The company's devices enable the patient's own body to naturally restore a new blood vessel or heart valve through a therapeutic approach called Endogenous Tissue Restoration (ETR).

Contact Information

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Primary Office
  • Seefeldstrasse 69
  • 8008 Zurich
  • Switzerland
+41 044 000 00 00

Xeltis Timeline

2017201820192020
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Xeltis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series D) 05-Sep-2019 $11.7M 0000 Completed Clinical Trials - General
3. Later Stage VC (Series C) 15-Nov-2017 000.00 000.00 Completed Clinical Trials - General
2. Later Stage VC (Series B) 24-Sep-2015 $33.7M $33.7M Completed Clinical Trials - General
1. Early Stage VC Completed Startup

Xeltis Competitors (17)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing
Amount
QT Vascular Corporation Singapore, Singapore 000.00 000000000 000.00
0000000 0000000000 Venture Capital-Backed Kirkland, WA 00 00000 00000000000 00000
000 Formerly PE-Backed Leesburg, VA 000 00000 000000&0 00000
000000000 Corporate Backed or Acquired Framingham, MA 000 00000 000000&0 00000
000000 Angel-Backed Eagan, MN 0000 0000000000 0000

Xeltis Executive Team (30)

Name Title Board Seat Contact Info
Eliane Schutte Chief Executive Officer & Board Member
Martijn Cox Ph.D Chief Technology Officer & Co-Founder
Mark La Meir Ph.D Independent Clinal Advisor
Christian Spaulding MD Medical Advisory Board Member
Francesco Maisano MD Medical Advisory Board Member

9 Former Executives

Xeltis Board Members (11)

To view Xeltis‘s full board member team, request access »
Name Representing Role Since
Christian Wenger Ph.D Self Board Member 000 0000
Clemens Van Blitterswijk Ph.D Life Sciences Partners Board Member 000 0000
Eliane Schutte Xeltis Chief Executive Officer & Board Member 000 0000
Karen Wagner Ysios Capital Board Member 000 0000
Michael Colson Self Chairman of the Scientific Advisory Board 000 0000

5 Former Board Members

Xeltis Investors (6)

To view Xeltis‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Ysios Capital Venture Capital Minority 000 0000 000000 0
Kurma Partners Venture Capital Minority 000 0000 000000 0
Life Sciences Partners Venture Capital Minority 000 0000 000000 0
StartAngels Network Angel Group Minority 000 0000 000000 0
VI Partners Venture Capital Minority 000 0000 000000 0

Ready to get started?

Request a free trial